BNGO - CIK 0001411690
Bionano Genomics, Inc. (BNGO) reported revenue of $28.51M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $28.51M | -7.4% |
| FY 2024 | $30.78M | -14.8% |
| FY 2023 | $36.12M | +29.9% |
| FY 2022 | $27.80M | +54.6% |
| FY 2021 | $17.98M | +111.5% |
| FY 2020 | $8.50M | -16.1% |
| FY 2019 | $10.13M | -15.6% |
| FY 2018 | $12.00M | +26.3% |
| FY 2017 |
Bionano Genomics, Inc. (BNGO) reported revenue of $28.51M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2017 and fiscal 2025, Bionano Genomics, Inc.'s revenue grew from $9.51M to $28.51M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $9.51M |
| - |